REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Cyclopentanohydrophenanthrene Ring System Doai Cyclopentanohydrophenanthrene Ring System DoaiCyclopentanohydrophenanthrene Ring System Doai patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/04/07 - 20070004689 - Antiangiogenic agents wherein Ra is selected from —OCH3, —OCH2CH3 or —CCCH3; and Z is selected from >C(H)—OH, >C(H)—O-alkyl, >C(H)—O-sulfamate, or >C(H)-dioxolane, where alkyl is a linear, branched and/or cyclic hydrocarbon chain comprising 1 to 10 carbons. ... 12/28/06 - 20060293292 - Methods of using acyl hydrazones as seh inhibitors Disclosed are hydrazine compounds useful as soluble epoxide hydrolase (sEH) inhibitors for treating cardiovascular diseases. ... 12/14/06 - 20060281720 - 5-androstenediol as an inhibitor of gliomas The invention relates to the field of pharmaceuticals for tumor-inhibitory effects. The 5-androstene 3β,17α diol (αAED) and 5-androstene 3β,17β diol (βAED), their esters and ethers, are taught herein to achieve tumor-inhibiting effect. The invention also relates to the field of pharmaceuticals for tumor-inhibitory effects and the use of 5-androstene 3β,7β,17β ... 12/14/06 - 20060281719 - Oestrogen-17-sulphamates as inhibitors of steroid sulphatase wherein R2 is any one of a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; and wherein said compound is capable of inhibiting steroid sulphatase (STS) activity and/or is capable of acting as a modulator of cell cycling and/or as a modulator of ... 12/07/06 - 20060276440 - Treatment of inflammatory disorders Ring A is optionally substituted, contains zero, one, two, or three double bonds, and is optionally fused to an aliphatic, aryl or heteroaryl ring; X is an optionally substituted 1 to 3 carbon aliphatic chain that is optionally fused to a monocyclic, optionally substituted, aliphatic, heterocyclic, aryl, or heteroaryl ring, ... 11/30/06 - 20060270641 - Method for chemoprevention of prostate cancer This invention relates to the chemoprevention of prostate cancer and, more particularly, to a method of suppressing or inhibiting latent prostate cancer comprising administering to a mammalian subject a chemopreventive agent, for example raloxifene, or its analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, ester, or N-oxide, or mixtures thereof. The ... 11/23/06 - 20060264411 - Control of biofilm formation The present invention provides a method for reducing or preventing the invasion of a bacterium into a tissue comprising modulating the expression of a cysB gene in the bacterium. The present invention further provides an in vivo method for reducing or preventing the formation of a biofilm in a tissue ... 11/09/06 - 20060252733 - Betulin, betulin derivatives, betulinic acid and betulinic acid derivatives as novel therapeutics in the treatment of disease of lipid and/or glucose metabolism The invention relates to method of modulating lipid metabolism comprising contacting a cell with betulin, a betulin derivative, betulinic acid, a betulinic acid derivative, or a related steroid-like compound. In some aspects, the invention relates to the treatment of disorders of lipid metabolism. The invention further relates to methods of ... 10/19/06 - 20060234989 - Formulations of quaternary ammonium neuromuscular blocking agents Muscle relaxant formulations which include one or more quaternary ammonium neuromuscular blocking agents have a reduced tendency for hydrolytic degradation, and therefore a longer shelf life stability, when combined with one or more organic anions having at least six carbon atoms and having a pKa of less than 4.0 (preferably ... 09/14/06 - 20060205700 - Non invasive method for prevention and treatment of cancer This invention relates to a novel non invasive method for preventing or treating cancer or its recurrence and to the novel use of compounds useful therein. Very low cost, rapid action and generally no side effects are also objects inherent to the invention, realized through novel use of otherwise well ... 08/31/06 - 20060194774 - Medicament for inhibiting tumour growth The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals. ... 08/17/06 - 20060183723 - Ethercarboxylic acid ester of sterol or stanol The disclosed invention relates to sterol and/or stanol esters of ethercarboxylic acids corresponding to general formula (I):R(OAlk)nOCH2COOH, in which R is a C1-50 alkyl, alkenyl and/or alkylphenyl group derived from an alcohol, OAlk stands for ring-opened ethylene oxide, propylene oxide and/or butylene oxide units and n is a number of ... 07/27/06 - 20060166951 - Compositions and methods for sterol isolation and purification Compositions and methods for isolating and purifying sterols, stanols, policosanols, and other organic molecules of interest are disclosed. The compositions encompass purified sterols comprising, for example, policosanols. Methods comprise solvent extraction of sterols from any solute comprising sterol-containing material. Such sterol-containing material may be in the form of plant material ... 07/27/06 - 20060166950 - Treatment of neovascularization disorders with squalamine Aminosterol compounds are described that are useful as inhibitors of the sodium/proton exchanger (NHE). Methods of using such aminosterols compounds are also enclosed, including those employing compounds that are inhibitors of a spectrum of NHEs as well as those using compounds that are inhibitors of only one specific NHE. Advantageous ... 07/13/06 - 20060154906 - Methods and related compositions for the non-surgical removal of fat Compositions and methods useful in the non-surgical removal of localized fat deposits in patients in need thereof using pharmacologically active detergents are disclosed. The pharmacologically active detergent compositions can additionally include anti-inflammatory agents, analgesics, dispersion agents and pharmaceutically acceptable excipients but do not contain phosphotidylcholine. The pharmacologically active detergent compositions ... 07/13/06 - 20060154905 - Nitrate esters of corticoid compounds and pharmaceutical applications thereof and use of the compounds as medicaments. ... 07/13/06 - 20060154904 - Betulinol derivatives as anti-hiv agents The present invention relates to methods of treating HIV-1 infection in a subject. These methods involve administering to the subject with HIV-1 infection a therapeutically effective amount of a conjugated or immunoconjugated betulinol derivative compound, or a pharmaceutically acceptable salt or derivative thereof, under conditions effective to treat the subject ... 07/13/06 - 20060154903 - Betulinol derivatives as anti-cancer agents Also disclosed are conjugated and immunoconjugated derivatives of the compound of Formula I as well as methods of making and using them. ... 06/29/06 - 20060142255 - Hypocholesteremic preparations containing phytostenolesters of conjugated fatty acids, and methods of reducing serum cholesterol levels using the same A hypocholesteremic preparation containing at least one phytostenol ester of a conjugated fatty acid having from about 6 to about 24 carbon atoms is disclosed. Methods of reducing serum cholesterol content in a mammal via administration of hypocholesteremic preparations described herein are also disclosed. ... 06/22/06 - 20060135495 - Anti-hiv agents with dual sites of action which are substituted at the 3 and 28 positions, along with pharmaceutical formulations containing the same and methods of treating viral infections employing the same. ... 06/22/06 - 20060135494 - Methods of treating injuries of the nervous system associated with hemorrhage Methods for treating injuries of the nervous system associated with hermorrhage by administering a hydrophilic bile acid, such as ursodeoxycholic acid (UDCA), salts thereof, and analogs thereof (e.g., glyco-, tauro-ursodeoxycholic acid, and other conjugated derivative). ... 06/15/06 - 20060128678 - Manganese based organometallic complexes, pharmaceutical compositions and dietetic products The invention relates to compounds and their uses, particularly in the pharmaceutical and dietetic industries. The invention discloses complexes having Mn-SOD like activities, as well as methods for treating various diseases associated with oxidative stress, including cancer and inflammatory conditions, by administering said compounds. It further deals with pharmaceutical compositions ... 04/06/06 - 20060074057 - Use of chenodeoxycholic acid for reducing adipose tissue Use of chenodeoxycholic acid is disclosed to reduce adipose tissue and thereby reduce weight in mammals. The chenodeoxycholic acid can be administered orally through the use of a tablet, pill, capsule or liquid suspension. ... 03/30/06 - 20060069070 - Treatment of fibrosis using fxr ligands The present invention relates to a method for inhibiting fibrosis that occurs in an organ where the farnesoid X receptor (FXR) is expressed. This method involves the step of administering a high potency, activating ligand of FXR in an effective amount to a patient who is not suffering from a ... 03/16/06 - 20060058271 - Methods for screening, studying, and treating dissorders with a component of mercurial toxicity The present invention is related to a method, system or process for screening, studying and treating disorders which have a component of mercurial including: autism, autism spectrum disorders, ADD, ADHD, mental retardation, Asperger's syndrome, childhood psychoses, stammering, stuttering, tics, repetitive movements, eating disorders, sleep disorders, enuresis, disturbances of emotion, developmental ... 02/16/06 - 20060035872 - Process for the preparation of 3-oximino steroids The present invention provides a method of preparing norelgestromin or norgestimate by reacting the corresponding 3-oxosteroid precursor with hydroxylamine HCl and a base to obtain a reaction mixture forming norelgestromin or norgestimate; monitoring the anti/syn ratio of the norelgestromin or norgestimate produced in the reaction mixture; adding a base to ... 02/16/06 - 20060035871 - Pulverulent phytosterol formulations A pulverulent phytosterol formulation comprising at least one phytosterol having a mean particle size ranging from 0.01 to 100 μm, a process for producing the pulverulent phytosterol formulation, and a food supplement, an animal feed, food or pharmaceutical or cosmetic preparation comprising the phytosterol formulation. ... 02/02/06 - 20060025389 - Methods of treating fungal infections using lupeol The invention is directed to methods of treating fungal and yeast infections using lupeol or solvates, hydrates, or clathrates thereof. The method also encompasses methods of treating fungal and yeast infections by administering to a mammal in need of such treatment a therapeutically effective amount of lupeol. Among the methods ... 01/26/06 - 20060019934 - Anti-hiv-1 activity of betulinol derivatives R2 is —H, —CH3, —CHO, —CH2OH, —CH2OCH3, —CH2OC(O)CH3, —COCH3, or —COOH, or a pharmaceutically acceptable salt or derivative thereof, under conditions effective to inhibit HIV-1 activity in the cell. A method of treating HIV-1 infection in a subject is also disclosed. This method involves administering a therapeutically effective amount of ... 01/19/06 - 20060014727 - Angiogenic compounds and uses thereof The invention provides sterol sulphate compounds and compositions that are capable of promoting angiogenesis. The invention also provides methods and uses for these compounds. ... 01/12/06 - 20060009427 - Androgen modulators The present invention is directed to a new class of 4-cycloalkoxy benzonitriles and to their use as androgen receptor modulators. Other aspects of the invention are directed to the use of these compounds to decrease excess sebum secretions and to stimulate hair growth. ... 01/05/06 - 20060003974 - Bile acid derived steroidal dimers with amphiphilic topology having antiproliferative activity Advances in the treatment of cancer required continued development of novel and improved therapeutic agents. A highly efficient modified process for the synthesis of bile acid derived steroidal dimers N1,N2-Ethylenediamine bis [cholic acid amide] and N1,N2-Ethylenediamine bis [deoxycholic acid amide] having novel amphiphile topology and remarkable antiproliferative activity is described. ... 12/08/05 - 20050272711 - Substance for lowering high cholesterol level in serum and methods for preparing and using the same The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble β-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of ... 12/08/05 - 20050272710 - Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration This invention is directed to methods for providing sustained systemic concentrations of therapeutic or prophylactic agents such as GABA analogs following oral administration to animals. This invention is also directed to compounds and pharmaceutical compositions that are used in such methods. ... 12/01/05 - 20050267080 - Methods and related compositions for reduction of fat Compositions and methods useful in the reduction of localized fat deposits in patients in need thereof using pharmacologically active detergents are disclosed. The pharmacologically active detergent compositions can additionally include anti-inflammatory agents, analgesics, dispersion or anti-dispersion agents and pharmaceutically acceptable excipients. The pharmacologically active detergent compositions are useful for treating ... 11/24/05 - 20050261259 - Phytosterol and/or phytostanol derivatives The present invention relates to a phytosterol and/or a phytostanol ester compound produced from the reaction of a phytosterol and/or a phytostanol with a polyunsaturated fatty acid (PUFA), wherein the polyunsaturated fatty acid has from 18 to 22 carbon atoms and at least three carbon-carbon double bonds. Processes for producing ... 11/24/05 - 20050261258 - Methods and compositions for the non-surgical removal of fat Compositions and methods useful in the non-surgical removal of localized fat deposits in patients in need thereof using pharmacologically active detergents are disclosed. The pharmacologically active detergent compositions can additionally include anti-inflammatory agents, analgesics, dispersion agents and pharmaceutically acceptable excipients but do not contain phosphotidylcholine. The pharmacologically active detergent compositions ... 11/17/05 - 20050256093 - Branched polyamine steroid derivatives are provided. The compounds show antimicrobial activity and may be used in the treatment and prevention of infections, in particular bacterial infections. ... 10/06/05 - 20050222098 - Regulation of meiosis Compounds of Formula I and methods of regulating the meiosis in a mammalian germ cell which method comprises administering an effective amount of the compound of Formula I to a germ cell in need of such a treatment. ... 10/06/05 - 20050222097 - Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity Sterol derivatives of formula (I) and a method for the production of the compounds, a medicament using one of the compounds and a pharmaceutical composition comprising the medicament. ... 09/29/05 - 20050215534 - 3-nitrogen-6, 7-dioxygen steroids and uses related thereto and pharmaceutically acceptable salts, solvates, stereoisomers and prodrugs thereof, in isolation or in mixture, wherein, independently at each occurrence: R1 and R2 are selected from hydrogen, oxygen so as to form nitro or oxime, amino, sulfate, and sulfonic acid, and organic groups having 1-30 carbons and optionally containing 1-6 heteroatoms ... 09/08/05 - 20050197322 - Compounds capable of binding to proteins constituting or associated with cytoskeletal elements, and their applications for the manufacture of medicaments The invention concerns the use of steroids and non-toxic compounds, capable of crossing the blood brain barrier characterized in that they are capable of binding the same site as pregnenolone on proteins constituting or associated with elements of the cytoskeleton and of displacing the MAP2-bound pregnenolone, and of influencing the ... 09/01/05 - 20050192259 - Aldosterone antagonist compositions for release during aldosterone acrophase A pharmaceutical composition is provided for administration to a subject mammal such as a human exhibiting a diurnal cycle of plasma aldosterone concentration, the composition comprising a delayed-release formulation of an aldosterone antagonist drug, e.g., eplerenone, in a therapeutically effective amount. The delayed-release formulation, when administered about 6 hours to ... 09/01/05 - 20050192258 - Antiangiogenic agents wherein the variables are defined in the specification. ... 09/01/05 - 20050192257 - Predictors for patients at risk for glaucoma from steroid therapy A patient's risk for increased intraocular pressure after being treated with a steroid for an ocular disease, such as macular edema or age related macular degeneration, is assessed. The patient receives an intraocular challenge dose of triamcinolone, and the patient's intraocular pressure before and after the challenge dose is compared. ... 08/25/05 - 20050187202 - Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols An efficient method for the synthesis of aminosterol compounds such as squalamine and compound 1436 is described. A method of the invention provides for regioselective sulfonation of a fused ring system. The fused ring system base can be, for example, a steroid ring base. The aminosterol compounds are effective as, ... 06/23/05 - 20050137176 - Use of a steroidal or non-steroidal ecr receptor ligand in a cosmetic or dermatological preparation for maintaining cutaneous homeostasis The present invention relates to the use of at least one EcR receptor ligand in a cosmetic or dermatological preparation for maintaining cutaneous homeostasis. The present invention also relates to a cosmetic treatment process for maintaining cutaneous homeostasis, which consists in applying a composition according to the invention. ... 06/23/05 - 20050137175 - Use of ecdysteroids for preparing dermatological or cosmetological anti-hair loss compositions The present invention relates to the use of at least one ecdysteroid for preparing cosmetic or dermatological compositions intended to prevent hair loss. ... 06/09/05 - 20050124592 - Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen Disclosed is a treatment of estrogen-deficiency related complaints in females that exhibit these complaints while they are on treatment with a drug which prevents the synthesis of endogenous estrogen. Such drugs are, e.g., anti-cancer drugs such as aromatase inhibitors. The invention resides in the use of tibolone, which has an ... ### FreshPatents.com Support |